Investigation of Community Reablement on Instrumental Activities of Daily Living in People With Schizophrenia

National Taipei University of Nursing and Health Sciences

Status: Completed

Conditions: Schizophrenia

Treatments: Other: RE-IADL; Other: General community rehabilitation

Study type: Interventional

Funder types: Other

Identifiers

NCT04350775

TCHIRB-10812015

Details and patient eligibility

About

This is a randomized controlled behavioral intervention trial to assess the efficacy of investigating program of Reablement-Instrumental Activities of Daily Living (RE-IADL) on schizophrenia patients at immediately and long-term.

Full description

Subjects will be randomized to intervention group and control group. The outcome measures include the Canadian Occupational Performance Measure, Instrumental Activities of Daily Living-3 Dimensions, Activities of Daily Living Rating Scale III, Frenchay Activities Index, Lawton Instrumental Activities of Daily Living, Mini Mental State Examination-2nd edition, Behavior Rating Inventory of Executive Function adult version, Allen Cognitive Level Screen-6th, Participation Measure-3 Domains, 4 Dimensions, Personal and Social Performance scale, Work Behavior Inventory, Schizophrenia-Quality of Life questionnaire, Beck Depression Inventory-II, and Functioning Scale of the Disability Evaluation System.

Enrollment: 80 patients

Sex: All

Ages: 20 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of schizophrenia by DSM-5
• age > 20 years
• Stable mental symptoms
• Willing to sign the subject's consent

Exclusion criteria

• History of severe brain injury
• Substance abuse
• Diagnosis of intellectual developmental disorder
• Unable to follow instructions

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

80 participants in 2 patient groups, including a placebo group

RE-IADL group

Experimental group

Description:

Reablement

Treatment:

Other: RE-IADL

Control group

Placebo Comparator group

Description:

General community rehabilitation

Treatment:

Other: General community rehabilitation